By Amina Niasse NEW YORK (Reuters) - About one-third of U.S. employer health plans are offering coverage of GLP-1 drugs for both diabetes management and weight loss, up from last year, according to a survey of global employers released on Thursday .
Analysis-Weight-loss drug forecasts jump to $150 billion as supply grows yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Analysis-Weight-Loss Drug Forecasts Jump to $150 Billion as Supply Grows usnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from usnews.com Daily Mail and Mail on Sunday newspapers.
As millions seek access to weight-loss drugs from Novo Nordisk and Eli Lilly, increasing supplies, possible wider usage and a growing number of would-be rivals are leading.
The United States and
Europe are taking steps to acquire or manufacture H5N1 bird flu
vaccines that could be used to protect at-risk poultry and dairy
workers, veterinarians and lab technicians,.